申请人:Schmidt Fanny
公开号:US20110319387A1
公开(公告)日:2011-12-29
The invention relates to a compound of the following formula (I),
or to a pharmaceutically acceptable salt thereof or to a stereoisomer or mixture of stereoisomers at any proportions, where: X
1
is a CH
2
or C═O group; X
2
is a linear saturated or unsaturated carbohydrate chain with 8 to 24 carbon atoms; R
1
is a hydrogen atom or an OH or (C
1
-C
6
)alkoxy group such as methoxy; and R
2
is a CH
3
or CH
2
OR
3
group, with R
3
being a hydrogen atom or a (C
1
-C
6
)alkyl, CO—(C
1
-C
6
)alkyl or NH—(C
1
-C
6
)alkyl group. The invention also relates to the use of said compound as a drug, in particular for treating neurodegenerative diseases, and to a method for preparing same.
本发明涉及以下式(I)的化合物,或其药学上可接受的盐,或其立体异构体或立体异构体的混合物,比例不限。其中:X1是CH2或C═O基团;X2是具有8至24个碳原子的线性饱和或不饱和碳水化合物链;R1是氢原子或OH或(C1-C6)烷氧基团,例如甲氧基;R2是CH3或CH2OR3基团,其中R3是氢原子或(C1-C6)烷基,CO-(C1-C6)烷基或NH-(C1-C6)烷基。本发明还涉及所述化合物作为药物的用途,特别是用于治疗神经退行性疾病,以及制备该化合物的方法。